Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …

Background and Aims HCV cure reduces but does not eliminate the risk of HCC. HCC
surveillance is recommended in populations where the incidence exceeds 1.5% per year. In …

Background & Aims Hepatocellular carcinoma (HCC) is a major cause of morbidity and
mortality in patients with advanced chronic liver disease (ACLD) caused by chronic hepatitis …

Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related mortality worldwide.
Early detection of HCC enables patients to avail curative therapies that can improve patient …

Chronic inflammation is linked to carcinogenesis, particularly in the digestive organs, ie, the
stomach, colon, and liver. The mechanism of this effect has, however, only partly been …

Chronic liver diseases, resulting from chronic injuries of various causes, lead to cirrhosis
with life-threatening complications including liver failure, portal hypertension, hepatocellular …

The hepatitis C virus (HCV), a single-stranded RNA virus belonging to the Flaviviridae
family, is a major cause of hepatocellular carcinoma (HCC) worldwide. Tumors caused by …

More than 50,000 people are diagnosed with hepatocellular carcinoma (HCC) every year in
Europe. Many cases are known to specialist liver centres years before they present with …

Liver fibrosis is a common link in the transformation of acute and chronic liver diseases to
cirrhosis. It is of great clinical significance to study the factors associated with the induction of …

Cirrhosis is an emerging major cause of the development of hepatocellular carcinoma
(HCC), but in non-alcoholic fatty liver disease (NAFLD), up to 50% of patients with HCC had …